Optional statement
At least 30% of patients with congestive heart failure have preserved systolic function in the absence of significant valvular heart disease. These patients have diastolic dysfunction. Patients are frequently older and hypertensive. The rate of hospitalization in these patients is similar to that in patients with systolic dysfunction. Mortality is intermediate between that of patients with systolic dysfunction heart failure and normal subjects. Diagnosis requires a clear demonstration of the presence of the heart failure syndrome, normal systolic function, and the absence of valvular disease that could increase left atrial pressures. The diagnosis is supported by evidence of diastolic dysfunction that, from a practical point of view, will be provided most frequently by tissue Doppler imaging. Few randomized data are available on efficacy of therapeutic approaches. Acute treatment centers on reducing central blood volume with diuretics and nitrates and controlling heart rate, particularly in the setting of atrial fibrillation. Further treatment centers on reversing underlying pathophysiologic changes, particularly left ventricular hypertrophy. Control of hypertension and antagonism of the renin-angiotensin-aldosterone system appear to be promising therapeutic approaches.
Similar content being viewed by others
References and Recommended Reading
Senni M, Triboulloy C, Rodeheffer R, et al.: Congestive heart failure in the community: a study of all incident cases in Olmstead County, Minnesota, in 1991. Circulation 1998, 98:2282–2289.
Cowie M, Fox K, Wood D, et al.: Hospitalization of patients with heart failure: a population-based study. Eur Heart J 2002, 23:877–885.
Hedberg P, Lonnberg I, Johnson T, et al.: Left ventricular systolic dysfunction in 75-year-old men and women: a population-based study. Eur Heart J 2001, 22:676–683.
Kitzman D, Gardin J, Gottdeiner J, et al.: Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 2001, 87:413–419.
Vasan R, Benjamen E, Levy D: Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995, 26:1565–1574.
Morgan S, Smith H, Simpson I, et al.: Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross-sectional survey. BMJ 1999, 318:368–372.
Gaasch W: Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA 1994, 27:1276–1280.
Kupari M, Lindroos M, Iivanainen A, et al.: Congestive heart failure in old age; prevalence, mechanisms and 4-year prognosis in the Helsinki Aging Study. J Intern Med 1997, 241:387–394.
Gandhi S, Powers J, Nomeir A, et al.: The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001, 344:17–22.
Devereux R, Roman M, Liu J, et al.: Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol 2000, 86:1090–1096.
Peyster E, Norman J, Domanski M: Prevalence and predictors of heart failure with preserved systolic function: community hospital admissions of a racially and gender diverse elderly population. J Card Fail 2004, 10:49–54.
Gottdiener J, Arnold A, Aurigemma G, et al.: Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000, 35:1628–1637.
Masoudi FA, Havranek EP, Smith G, et al.: Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003, 41:217–223.
Zile M, Brutsaert D: New concepts in diastolic dysfunction and diastolic heart failure: part 1. Circulation 2002, 105:1387–1393. Excellent two-part review that summarizes the field; particularly useful for clinicians and clinical investigators.
Aurigemma G, Gaasch W: Diastolic heart failure. N Engl J Med 2004, 351:1097–1105.
Frenneaux M, Porter A, Caforio A, et al.: Determinates of exercise capacity in hypertrophic cardiomyopathy. J Am Coll Cardiol 1989, 13:1521–1526.
Mancini D, Henson D, LaManca J, et al.: Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992, 86:909–918.
Massie B, Conway M, Yonge R, et al.: Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 1987, 76:1009–1019.
Zile M, Baicu C, Gaasch W, et al.: Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004, 350:1953–1959.
Kass D, Bronzwaer J, Daulos W: What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 2004, 94:1533–1542. Scholarly review of underlying mechanisms; particularly useful for investigators in the field.
How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure [no authors listed]. Eur Heart J 1998, 19:990–1003.
Weiss J, Frederickson J, Weisfeldt M: Hemodynamics determinants of the time course of fall in canine left ventricular pressure. J Clin Invest 1976, 58:83–95.
Mirsky I, Pasipoularides A: Clinical assessment of diastolic function. Prog Cardiovasc Dis 1990, 32:291–318.
Zile M, Baicu C: Alterations in ventricular function: diastolic heart failure. In Heart Failure: A Companion to Braunwald’s Heart Disease. Edited by Mann D.Philadelphia: Elsevier Science; 2004:209–227.
Ommen S, Nishimura R: A clinical approach to the assessment of left ventricular diastolic function by Doppler echocardiography: update 2003. Heart 2003, 89(suppl 3):iii18-iii23.
Nikolay N, White K: Application of tissue Doppler imaging in cardiology. Cardiology 2004, 101:170–184.
Ommen S, Nishimura R, Appleton C, et al.: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures; a comparative simultaneous Doppler-catheterization study. Circulation 2000, 102:1788–1794.
Vasan R, Levy D: Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000, 101:2118–2121.
Zile M, Gaasch W, Carroll J, et al.: Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001, 104:779–782.
Goyal D, Choudhary A, Gregory Y, et al.: Diastolic heart failure: recognition, diagnosis and management. Expert Opin Pharmacother 2004, 5:1745–1754.
Hunt S, Baker D, Chin M, et al.: ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American Heart Association/American College of Cardiology Task Force on Practice Guidelines. J Am Coll Cardiol 2001, 38:2101–2113.
Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362:777–781.
Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341:709–717.
Pitt B, Remme W, Zannad F, et al.: For the eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348:1309–1321.
Rocha R, Rudolph AE, Frierdich GE, et al.: Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 2002, 283:H1802-H1810.
Sun Y, Zhang J, Lu L, et al.: Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 2002, 161:1773–1781.
Suzuki G, Morita H, Mishima T, et al.: Effects of longterm monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation 2002, 106:2967–2972.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Domanski, M., Peyster, E. Heart failure with preserved systolic function. Curr Treat Options Cardio Med 7, 55–59 (2005). https://doi.org/10.1007/s11936-005-0006-2
Issue Date:
DOI: https://doi.org/10.1007/s11936-005-0006-2